![Namandje Bumpus](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 458 199 $ op 31-05-2026
Namandje N.
Bumpus is an Independent Director at Recursion Pharmaceuticals, Inc. since 2025.
Dr. Bumpus is Senior VP, Chief Innovation & Scientific Officer at Charles River Laboratories International, Inc. since 2026.
Dr. Bumpus is a Venture Partner at F-Prime Inc. since 2025.
Formerly, Dr. Bumpus was a Director at AI Proteins, Inc. Dr. Bumpus was a Professor at The Johns Hopkins University School of Medicine from 2020 to 2022.
Dr. Bumpus completed undergraduate studies at Occidental College in 2003 and earned a doctorate from the University of Michigan in 2007.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-06-2026 | 127.632 ( 0,02% ) | 458 199 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 15-03-2025 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Hoofd Techniek/Wetenschap/O&O | 12-01-2026 |
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance F-Prime invests in companies located in Asia, Europe, North America and South America. The firm targets companies operating in the fields of life sciences, technology, healthtech & services and crypto sectors. It provides financing for seed, early and later stage transactions. | Private Equity Investor | 01-05-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-2022 |
AI Proteins, Inc.
 AI Proteins, Inc. Packaged SoftwareTechnology Services Develops AI powered protein therapeutics discovery platform | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 7 |
|---|---|
Charles River Laboratories International, Inc.
 Charles River Laboratories International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory testing and research services on a contract basis | Commercial Services |
Recursion Pharmaceuticals, Inc.
 Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
Occidental College
 Occidental College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Impresa Management LLC
Impresa Management LLC Investment ManagersFinance F-Prime invests in companies located in Asia, Europe, North America and South America. The firm targets companies operating in the fields of life sciences, technology, healthtech & services and crypto sectors. It provides financing for seed, early and later stage transactions. | Finance |
AI Proteins, Inc.
AI Proteins, Inc. Packaged SoftwareTechnology Services Develops AI powered protein therapeutics discovery platform | Technology Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau
